In lung cancer, TM4SF4 expression is upregulated where it promotes tumor growth, migration, and invasion through activation of PI3K/AKT and JAK2/STAT3 pathways, as well as preserving cancer stem cell features [94–97]. Here, JAK2 is linked to lung carcinoma.